Ivermectin, is a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and safety of ivermectin among adult SARS-CoV-2 patients.
The trial included 72 hospitalized patients in Dhaka, Bangladesh, who were assigned to one of three groups: oral ivermectin alone (12 mg once daily for 5 days), oral ivermectin in combination with doxycycline (12 mg ivermectin single dose and 200 mg doxycycline on day 1, followed by 100 mg every 12 h for the next 4 days), and a placebo control group.
Clinical symptoms of fever, cough, and sore throat were comparable among the three groups. Virological clearance was earlier in the 5-day ivermectin treatment arm when compared to the placebo group (9.7 days vs 12.7 days; p = 0.02), but this was not the case for the ivermectin + doxycycline arm (11.5 days; p = 0.27). There were no severe adverse drug events recorded in the study. A 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild COVID-19. Larger trials will be needed to confirm these preliminary findings. Source: pubmed.ncbi.nlm.nih.gov/33278625/
If Ivermectin is a SAFE treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), why have governments throughout the world purchased millions of doses of an untested Covid Jabs?
The FLCCC ALLIANCE recommends:
lvermectin Prophylaxis for high risk individuals
0.2 mg/kg* — one dose on day 1 and day 3, then take one dose every 4 weeks
Post COVID-19 exposure prophylaxis** 0.2 mg/kg* — one dose on day 1 and day 3
Vitamin D3 1,000–3,000 IU/day Vitamin C 1,000mg twice a day Quercetin 250mg/day Zinc 50mg/day Melatonin 6mg before bedtime (causes drowsiness)